Zynerba Pharmaceuticals Ownership 2024 | Who Owns Zynerba Pharmaceuticals Now?
Institutional Ownership
0.03%
Insider Ownership
6.07%
Retail Ownership
93.90%
Institutional Holders
1.00
Zynerba Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -20,875 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -282 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -2,464 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -46,072 | -100.00% | - | Dec 31, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -100 | -100.00% | - | Dec 31, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -37,596 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -34,783 | -100.00% | - | Dec 31, 2023 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | - | - | - | -2,283,979 | -100.00% | - | Dec 31, 2023 |
| HM PAYSON & CO | - | - | - | -50 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -605,700 | -100.00% | - | Dec 31, 2023 |
| CSS LLC/IL | - | - | - | -476,831 | -100.00% | - | Dec 31, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -805 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -37,934 | -100.00% | - | Dec 31, 2023 |
| DELTEC ASSET MANAGEMENT LLC | - | - | - | -475,000 | -100.00% | - | Dec 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -325,237 | -100.00% | - | Dec 31, 2023 |
| GHP INVESTMENT ADVISORS, INC. | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
| - | - | - | -120,121 | -100.00% | - | Dec 31, 2023 | |
| HRT FINANCIAL LP | - | - | - | -203,229 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,814 | -100.00% | - | Dec 31, 2023 |
| CETERA ADVISOR NETWORKS LLC | - | - | - | -22,124 | -100.00% | - | Dec 31, 2023 |
Zynerba Pharmaceuticals's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -20,875 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -282 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -2,464 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -46,072 | -100.00% | - | Dec 31, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -100 | -100.00% | - | Dec 31, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -37,596 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -34,783 | -100.00% | - | Dec 31, 2023 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | - | - | - | -2,283,979 | -100.00% | - | Dec 31, 2023 |
| HM PAYSON & CO | - | - | - | -50 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -605,700 | -100.00% | - | Dec 31, 2023 |
| CSS LLC/IL | - | - | - | -476,831 | -100.00% | - | Dec 31, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -805 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -37,934 | -100.00% | - | Dec 31, 2023 |
| DELTEC ASSET MANAGEMENT LLC | - | - | - | -475,000 | -100.00% | - | Dec 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -325,237 | -100.00% | - | Dec 31, 2023 |
| GHP INVESTMENT ADVISORS, INC. | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
| - | - | - | -120,121 | -100.00% | - | Dec 31, 2023 | |
| HRT FINANCIAL LP | - | - | - | -203,229 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,814 | -100.00% | - | Dec 31, 2023 |
| CETERA ADVISOR NETWORKS LLC | - | - | - | -22,124 | -100.00% | - | Dec 31, 2023 |
The largest Zynerba Pharmaceuticals shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Zynerba Pharmaceuticals (ZYNE), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| IRON HORSE WEALTH MANAGEMENT, LLC | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
| LINDBROOK CAPITAL, LLC | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
| GHP INVESTMENT ADVISORS, INC. | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
| HM PAYSON & CO | - | - | - | -50 | -100.00% | - | Dec 31, 2023 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -100 | -100.00% | - | Dec 31, 2023 |
| CREATIVE PLANNING | - | - | - | -100 | -100.00% | - | Dec 31, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -100 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -282 | -100.00% | - | Dec 31, 2023 |
| SOUND INCOME STRATEGIES, LLC | - | - | - | -350 | -100.00% | - | Dec 31, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -805 | -100.00% | - | Dec 31, 2023 |
| FOUNDERS CAPITAL MANAGEMENT | - | - | - | -2,000 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -2,464 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,814 | -100.00% | - | Dec 31, 2023 |
| KEY FINANCIAL INC | - | - | - | -7,500 | -100.00% | - | Dec 31, 2023 |
| KING WEALTH | - | - | - | -16,000 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -16,161 | -100.00% | - | Dec 31, 2023 |
| XTX TOPCO LTD | - | - | - | -18,793 | -100.00% | - | Dec 31, 2023 |
| UBS GROUP AG | - | - | - | -20,385 | -100.00% | - | Dec 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -20,875 | -100.00% | - | Dec 31, 2023 |
| CETERA ADVISOR NETWORKS LLC | - | - | - | -22,124 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Zynerba Pharmaceuticals's largest institutional buyer is IRON HORSE WEALTH MANAGEMENT, LLC. The company purchased -1.00 stocks of ZYNE, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BERYL CAPITAL MANAGEMENT LLC | - | - | - | -4,898,927 | -100.00% | - | Dec 31, 2023 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | - | - | - | -2,283,979 | -100.00% | - | Dec 31, 2023 |
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -620,019 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -605,700 | -100.00% | - | Dec 31, 2023 |
| CSS LLC/IL | - | - | - | -476,831 | -100.00% | - | Dec 31, 2023 |
| DELTEC ASSET MANAGEMENT LLC | - | - | - | -475,000 | -100.00% | - | Dec 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -325,237 | -100.00% | - | Dec 31, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -282,478 | -100.00% | - | Dec 31, 2023 |
| CRYSTALLINE MANAGEMENT INC. | - | - | - | -230,817 | -100.00% | - | Dec 31, 2023 |
| PENSERRA CAPITAL MANAGEMENT LLC | - | - | - | -220,858 | -100.00% | - | Dec 31, 2023 |
| HRT FINANCIAL LP | - | - | - | -203,229 | -100.00% | - | Dec 31, 2023 |
| PENDERFUND CAPITAL MANAGEMENT LTD. | - | - | - | -123,444 | -100.00% | - | Dec 31, 2023 |
| - | - | - | -120,121 | -100.00% | - | Dec 31, 2023 | |
| FIFTH LANE CAPITAL, LP | - | - | - | -100,000 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -46,072 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -37,934 | -100.00% | - | Dec 31, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -37,596 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -34,783 | -100.00% | - | Dec 31, 2023 |
| CETERA ADVISOR NETWORKS LLC | - | - | - | -22,124 | -100.00% | - | Dec 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -20,875 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Zynerba Pharmaceuticals's biggest institutional seller is BERYL CAPITAL MANAGEMENT LLC. The company sold -4.90M shares of ZYNE, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BERYL CAPITAL MANAGEMENT LLC | - | - | - | -4,898,927 | -100.00% | - | Dec 31, 2023 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | - | - | - | -2,283,979 | -100.00% | - | Dec 31, 2023 |
| YAKIRA CAPITAL MANAGEMENT, INC. | - | - | - | -620,019 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -605,700 | -100.00% | - | Dec 31, 2023 |
| CSS LLC/IL | - | - | - | -476,831 | -100.00% | - | Dec 31, 2023 |
| DELTEC ASSET MANAGEMENT LLC | - | - | - | -475,000 | -100.00% | - | Dec 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -325,237 | -100.00% | - | Dec 31, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -282,478 | -100.00% | - | Dec 31, 2023 |
| CRYSTALLINE MANAGEMENT INC. | - | - | - | -230,817 | -100.00% | - | Dec 31, 2023 |
| PENSERRA CAPITAL MANAGEMENT LLC | - | - | - | -220,858 | -100.00% | - | Dec 31, 2023 |
| HRT FINANCIAL LP | - | - | - | -203,229 | -100.00% | - | Dec 31, 2023 |
| PENDERFUND CAPITAL MANAGEMENT LTD. | - | - | - | -123,444 | -100.00% | - | Dec 31, 2023 |
| - | - | - | -120,121 | -100.00% | - | Dec 31, 2023 | |
| FIFTH LANE CAPITAL, LP | - | - | - | -100,000 | -100.00% | - | Dec 31, 2023 |
| NORTHERN TRUST CORP | - | - | - | -46,072 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -37,934 | -100.00% | - | Dec 31, 2023 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -37,596 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -34,783 | -100.00% | - | Dec 31, 2023 |
| CETERA ADVISOR NETWORKS LLC | - | - | - | -22,124 | -100.00% | - | Dec 31, 2023 |
| JPMORGAN CHASE & CO | - | - | - | -20,875 | -100.00% | - | Dec 31, 2023 |
| UBS GROUP AG | - | - | - | -20,385 | -100.00% | - | Dec 31, 2023 |
| XTX TOPCO LTD | - | - | - | -18,793 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -16,161 | -100.00% | - | Dec 31, 2023 |
| KING WEALTH | - | - | - | -16,000 | -100.00% | - | Dec 31, 2023 |
| KEY FINANCIAL INC | - | - | - | -7,500 | -100.00% | - | Dec 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -2,814 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -2,464 | -100.00% | - | Dec 31, 2023 |
| FOUNDERS CAPITAL MANAGEMENT | - | - | - | -2,000 | -100.00% | - | Dec 31, 2023 |
| RHUMBLINE ADVISERS | - | - | - | -805 | -100.00% | - | Dec 31, 2023 |
| SOUND INCOME STRATEGIES, LLC | - | - | - | -350 | -100.00% | - | Dec 31, 2023 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -282 | -100.00% | - | Dec 31, 2023 |
| HARBOUR INVESTMENTS, INC. | - | - | - | -100 | -100.00% | - | Dec 31, 2023 |
| CREATIVE PLANNING | - | - | - | -100 | -100.00% | - | Dec 31, 2023 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -100 | -100.00% | - | Dec 31, 2023 |
| HM PAYSON & CO | - | - | - | -50 | -100.00% | - | Dec 31, 2023 |
| GHP INVESTMENT ADVISORS, INC. | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
| LINDBROOK CAPITAL, LLC | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
| IRON HORSE WEALTH MANAGEMENT, LLC | - | - | - | -1 | -100.00% | - | Dec 31, 2023 |
Zynerba Pharmaceuticals's largest sold out institutional shareholder by shares sold is BERYL CAPITAL MANAGEMENT LLC, sold -4.90M shares, valued at -, as of undefined.
Zynerba Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ETF Managers Trust | 0.09% | 723,151 | - | - | Dec 31, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 37,481 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.07% | 273,401 | - | - | Mar 28, 2024 |
| VANGUARD EXPLORER FUND | 0.04% | 545,001 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.02% | 52,200 | - | - | Mar 28, 2024 |
| Global X Funds | 0.01% | 567,893 | - | - | Jan 31, 2024 |
| Amplify ETF Trust | 0.01% | 220,858 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 3,839 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 35,338 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,125,956 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 797 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 59,400 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 408,872 | - | - | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 7,600 | - | - | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 18,610 | - | - | Mar 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 30,393 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 37,596 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 18,733 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,835 | - | - | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 28,949 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 2,438 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 4,673 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 12,238 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 190 | - | - | Apr 30, 2021 |
| Fidelity Rutland Square Trust II | 0.00% | 385,024 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 638 | - | - | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 16,019 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,484 | - | - | Mar 31, 2024 |
| Investment Managers Series Trust II | 0.00% | 1,500 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 16,116 | - | - | Mar 28, 2024 |
| Dimensional ETF Trust | 0.00% | 47,239 | - | - | Jan 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 1,626 | - | - | Mar 31, 2024 |
| VALIC Co I | 0.00% | 21,500 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 3,200 | -200 | -5.88% | Mar 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 3,315 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 44,968 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,473 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,037 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 86,920 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 800 | - | - | Mar 28, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 5,699 | - | - | Jan 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 46,478 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,000 | - | - | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 21,189 | - | - | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 7,772 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 24,900 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 870 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,576 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 3,269 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 11,872 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 41,902 | - | - | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 8,058 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 1,301 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,814 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,108 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 8,200 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 16 | - | - | Jan 31, 2024 |
Zynerba Pharmaceuticals's largest mutual fund holder by % of total assets is "ETF Managers Trust", owning 723.15K shares, compromising 0.09% of its total assets.
Zynerba Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 1 | - |
| 30 Sep, 23 | 44 | 7.32% |
| 30 Jun, 23 | 41 | - |
| 31 Mar, 23 | 41 | -18.00% |
| 31 Dec, 22 | 50 | -1.96% |
| 30 Sep, 22 | 51 | 13.33% |
| 30 Jun, 22 | 45 | -13.46% |
| 31 Mar, 22 | 52 | -8.77% |
| 31 Dec, 21 | 57 | -5.00% |
| 30 Sep, 21 | 60 | -14.29% |
| 30 Jun, 21 | 70 | 4.48% |
| 31 Mar, 21 | 67 | 11.67% |
| 31 Dec, 20 | 60 | -7.69% |
| 30 Sep, 20 | 65 | -27.78% |
| 30 Jun, 20 | 90 | 13.92% |
| 31 Mar, 20 | 79 | -9.20% |
| 31 Dec, 19 | 87 | -6.45% |
| 30 Sep, 19 | 93 | 10.71% |
| 30 Jun, 19 | 84 | 27.27% |
| 31 Mar, 19 | 66 | 3.13% |
| 31 Dec, 18 | 64 | -15.79% |
| 30 Sep, 18 | 76 | 11.76% |
| 30 Jun, 18 | 68 | -2.86% |
| 31 Mar, 18 | 70 | -1.41% |
| 31 Dec, 17 | 71 | -10.13% |
| 30 Sep, 17 | 79 | -3.66% |
| 30 Jun, 17 | 82 | 10.81% |
| 31 Mar, 17 | 74 | 94.74% |
| 31 Dec, 16 | 38 | 58.33% |
| 30 Sep, 16 | 24 | -11.11% |
| 30 Jun, 16 | 27 | -10.00% |
| 31 Mar, 16 | 30 | -3.23% |
| 31 Dec, 15 | 31 | 29.17% |
| 30 Sep, 15 | 24 | - |
As of 31 Mar 24, 1 institutions are holding Zynerba Pharmaceuticals's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 12,732 | - |
| 30 Sep, 23 | 11,505,090 | 115.69% |
| 30 Jun, 23 | 5,333,968 | -16.72% |
| 31 Mar, 23 | 6,404,937 | -19.88% |
| 31 Dec, 22 | 7,993,858 | -26.62% |
| 30 Sep, 22 | 10,893,886 | -0.76% |
| 30 Jun, 22 | 10,977,729 | -7.98% |
| 31 Mar, 22 | 11,929,527 | -10.04% |
| 31 Dec, 21 | 13,261,081 | -1.82% |
| 30 Sep, 21 | 13,507,038 | -7.70% |
| 30 Jun, 21 | 14,633,650 | 62.00% |
| 31 Mar, 21 | 9,032,867 | 40.63% |
| 31 Dec, 20 | 6,423,044 | 19.30% |
| 30 Sep, 20 | 5,384,037 | -28.85% |
| 30 Jun, 20 | 7,566,810 | -17.82% |
| 31 Mar, 20 | 9,207,415 | -14.14% |
| 31 Dec, 19 | 10,723,902 | 2.24% |
| 30 Sep, 19 | 10,488,958 | 23.31% |
| 30 Jun, 19 | 8,506,246 | 269.04% |
| 31 Mar, 19 | 2,304,941 | -14.50% |
| 31 Dec, 18 | 2,695,831 | -7.27% |
| 30 Sep, 18 | 2,907,327 | 15.99% |
| 30 Jun, 18 | 2,506,442 | -16.00% |
| 31 Mar, 18 | 2,983,894 | -23.93% |
| 31 Dec, 17 | 3,922,581 | 8.35% |
| 30 Sep, 17 | 3,620,370 | -20.40% |
| 30 Jun, 17 | 4,547,935 | 29.62% |
| 31 Mar, 17 | 3,508,720 | 68.85% |
| 31 Dec, 16 | 2,077,955 | 3.16% |
| 30 Sep, 16 | 2,014,374 | -7.94% |
| 30 Jun, 16 | 2,188,203 | -20.76% |
| 31 Mar, 16 | 2,761,451 | 2.19% |
| 31 Dec, 15 | 2,702,257 | 13.48% |
| 30 Sep, 15 | 2,381,256 | - |
Zynerba Pharmaceuticals (ZYNE) has 12.73K shares outstanding as of 31 Mar 24, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 0.03% | - |
| 30 Sep, 23 | 22.94% | 20.28% |
| 30 Jun, 23 | 10.64% | 6.08% |
| 31 Mar, 23 | 13.22% | 3.77% |
| 31 Dec, 22 | 18.74% | 3.02% |
| 30 Sep, 22 | 24.90% | 3.54% |
| 30 Jun, 22 | 26.51% | 3.03% |
| 31 Mar, 22 | 29.60% | 2.72% |
| 31 Dec, 21 | 32.97% | 2.90% |
| 30 Sep, 21 | 33.69% | 2.53% |
| 30 Jun, 21 | 36.52% | 7.19% |
| 31 Mar, 21 | 22.55% | 3.99% |
| 31 Dec, 20 | 23.77% | 7.01% |
| 30 Sep, 20 | 18.41% | 2.19% |
| 30 Jun, 20 | 28.99% | 1.87% |
| 31 Mar, 20 | 39.35% | 1.66% |
| 31 Dec, 19 | 48.74% | 2.38% |
| 30 Sep, 19 | 45.24% | 3.06% |
| 30 Jun, 19 | 38.46% | 27.39% |
| 31 Mar, 19 | 11.85% | 3.82% |
| 31 Dec, 18 | 17.61% | 5.73% |
| 30 Sep, 18 | 17.53% | 5.09% |
| 30 Jun, 18 | 18.56% | 3.78% |
| 31 Mar, 18 | 22.16% | 2.59% |
| 31 Dec, 17 | 29.22% | 3.83% |
| 30 Sep, 17 | 27.64% | 2.28% |
| 30 Jun, 17 | 34.84% | 4.12% |
| 31 Mar, 17 | 29.08% | 5.54% |
| 31 Dec, 16 | 22.91% | 4.48% |
| 30 Sep, 16 | 22.60% | 3.71% |
| 30 Jun, 16 | 24.70% | 2.52% |
| 31 Mar, 16 | 31.29% | 3.63% |
| 31 Dec, 15 | 29.37% | 1.89% |
| 30 Sep, 15 | 39.39% | - |
As of 31 Mar 24, Zynerba Pharmaceuticals is held by 0.03% institutional shareholders, representing a 0.00% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 1 | - |
| 30 Sep, 23 | 22 | 83.33% |
| 30 Jun, 23 | 12 | -7.69% |
| 31 Mar, 23 | 13 | -45.83% |
| 31 Dec, 22 | 24 | 14.29% |
| 30 Sep, 22 | 21 | 10.53% |
| 30 Jun, 22 | 19 | -20.83% |
| 31 Mar, 22 | 24 | - |
| 31 Dec, 21 | 24 | - |
| 30 Sep, 21 | 24 | -36.84% |
| 30 Jun, 21 | 38 | - |
| 31 Mar, 21 | 38 | 26.67% |
| 31 Dec, 20 | 30 | 30.43% |
| 30 Sep, 20 | 23 | -52.08% |
| 30 Jun, 20 | 48 | 54.84% |
| 31 Mar, 20 | 31 | -24.39% |
| 31 Dec, 19 | 41 | -28.07% |
| 30 Sep, 19 | 57 | 3.64% |
| 30 Jun, 19 | 55 | 77.42% |
| 31 Mar, 19 | 31 | 40.91% |
| 31 Dec, 18 | 22 | -38.89% |
| 30 Sep, 18 | 36 | 38.46% |
| 30 Jun, 18 | 26 | -10.34% |
| 31 Mar, 18 | 29 | -19.44% |
| 31 Dec, 17 | 36 | -10.00% |
| 30 Sep, 17 | 40 | -6.98% |
| 30 Jun, 17 | 43 | -14.00% |
| 31 Mar, 17 | 50 | 108.33% |
| 31 Dec, 16 | 24 | 71.43% |
| 30 Sep, 16 | 14 | -6.67% |
| 30 Jun, 16 | 15 | - |
| 31 Mar, 16 | 15 | -25.00% |
| 31 Dec, 15 | 20 | -16.67% |
| 30 Sep, 15 | 24 | - |
1 institutional shareholders have increased their position in ZYNE stock as of 31 Mar 24 compared to 22 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | - | - |
| 30 Sep, 23 | 10 | -16.67% |
| 30 Jun, 23 | 12 | 9.09% |
| 31 Mar, 23 | 11 | -26.67% |
| 31 Dec, 22 | 15 | -6.25% |
| 30 Sep, 22 | 16 | 14.29% |
| 30 Jun, 22 | 14 | - |
| 31 Mar, 22 | 14 | -22.22% |
| 31 Dec, 21 | 18 | -5.26% |
| 30 Sep, 21 | 19 | 18.75% |
| 30 Jun, 21 | 16 | 128.57% |
| 31 Mar, 21 | 7 | -36.36% |
| 31 Dec, 20 | 11 | -60.71% |
| 30 Sep, 20 | 28 | 47.37% |
| 30 Jun, 20 | 19 | -24.00% |
| 31 Mar, 20 | 25 | 19.05% |
| 31 Dec, 19 | 21 | 110.00% |
| 30 Sep, 19 | 10 | 11.11% |
| 30 Jun, 19 | 9 | -43.75% |
| 31 Mar, 19 | 16 | -36.00% |
| 31 Dec, 18 | 25 | 47.06% |
| 30 Sep, 18 | 17 | -22.73% |
| 30 Jun, 18 | 22 | 22.22% |
| 31 Mar, 18 | 18 | -5.26% |
| 31 Dec, 17 | 19 | 11.76% |
| 30 Sep, 17 | 17 | -15.00% |
| 30 Jun, 17 | 20 | 150.00% |
| 31 Mar, 17 | 8 | 33.33% |
| 31 Dec, 16 | 6 | - |
| 30 Sep, 16 | - | -100.00% |
| 30 Jun, 16 | 9 | 28.57% |
| 31 Mar, 16 | 7 | -12.50% |
| 31 Dec, 15 | 8 | - |
| 30 Sep, 15 | - | - |
- institutional shareholders have reduced their position in ZYNE stock as of 31 Mar 24 compared to 10 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 1 | - | 12,732 | - | 0.03% | - | 1 | - | - | - |
| 30 Sep, 23 | 44 | 7.32% | 11,505,090 | 115.69% | 22.94% | 20.28% | 22 | 83.33% | 10 | -16.67% |
| 30 Jun, 23 | 41 | - | 5,333,968 | -16.72% | 10.64% | 6.08% | 12 | -7.69% | 12 | 9.09% |
| 31 Mar, 23 | 41 | -18.00% | 6,404,937 | -19.88% | 13.22% | 3.77% | 13 | -45.83% | 11 | -26.67% |
| 31 Dec, 22 | 50 | -1.96% | 7,993,858 | -26.62% | 18.74% | 3.02% | 24 | 14.29% | 15 | -6.25% |
| 30 Sep, 22 | 51 | 13.33% | 10,893,886 | -0.76% | 24.90% | 3.54% | 21 | 10.53% | 16 | 14.29% |
| 30 Jun, 22 | 45 | -13.46% | 10,977,729 | -7.98% | 26.51% | 3.03% | 19 | -20.83% | 14 | - |
| 31 Mar, 22 | 52 | -8.77% | 11,929,527 | -10.04% | 29.60% | 2.72% | 24 | - | 14 | -22.22% |
| 31 Dec, 21 | 57 | -5.00% | 13,261,081 | -1.82% | 32.97% | 2.90% | 24 | - | 18 | -5.26% |
| 30 Sep, 21 | 60 | -14.29% | 13,507,038 | -7.70% | 33.69% | 2.53% | 24 | -36.84% | 19 | 18.75% |
| 30 Jun, 21 | 70 | 4.48% | 14,633,650 | 62.00% | 36.52% | 7.19% | 38 | - | 16 | 128.57% |
| 31 Mar, 21 | 67 | 11.67% | 9,032,867 | 40.63% | 22.55% | 3.99% | 38 | 26.67% | 7 | -36.36% |
| 31 Dec, 20 | 60 | -7.69% | 6,423,044 | 19.30% | 23.77% | 7.01% | 30 | 30.43% | 11 | -60.71% |
| 30 Sep, 20 | 65 | -27.78% | 5,384,037 | -28.85% | 18.41% | 2.19% | 23 | -52.08% | 28 | 47.37% |
| 30 Jun, 20 | 90 | 13.92% | 7,566,810 | -17.82% | 28.99% | 1.87% | 48 | 54.84% | 19 | -24.00% |
| 31 Mar, 20 | 79 | -9.20% | 9,207,415 | -14.14% | 39.35% | 1.66% | 31 | -24.39% | 25 | 19.05% |
| 31 Dec, 19 | 87 | -6.45% | 10,723,902 | 2.24% | 48.74% | 2.38% | 41 | -28.07% | 21 | 110.00% |
| 30 Sep, 19 | 93 | 10.71% | 10,488,958 | 23.31% | 45.24% | 3.06% | 57 | 3.64% | 10 | 11.11% |
| 30 Jun, 19 | 84 | 27.27% | 8,506,246 | 269.04% | 38.46% | 27.39% | 55 | 77.42% | 9 | -43.75% |
| 31 Mar, 19 | 66 | 3.13% | 2,304,941 | -14.50% | 11.85% | 3.82% | 31 | 40.91% | 16 | -36.00% |
| 31 Dec, 18 | 64 | -15.79% | 2,695,831 | -7.27% | 17.61% | 5.73% | 22 | -38.89% | 25 | 47.06% |
| 30 Sep, 18 | 76 | 11.76% | 2,907,327 | 15.99% | 17.53% | 5.09% | 36 | 38.46% | 17 | -22.73% |
| 30 Jun, 18 | 68 | -2.86% | 2,506,442 | -16.00% | 18.56% | 3.78% | 26 | -10.34% | 22 | 22.22% |
| 31 Mar, 18 | 70 | -1.41% | 2,983,894 | -23.93% | 22.16% | 2.59% | 29 | -19.44% | 18 | -5.26% |
| 31 Dec, 17 | 71 | -10.13% | 3,922,581 | 8.35% | 29.22% | 3.83% | 36 | -10.00% | 19 | 11.76% |
| 30 Sep, 17 | 79 | -3.66% | 3,620,370 | -20.40% | 27.64% | 2.28% | 40 | -6.98% | 17 | -15.00% |
| 30 Jun, 17 | 82 | 10.81% | 4,547,935 | 29.62% | 34.84% | 4.12% | 43 | -14.00% | 20 | 150.00% |
| 31 Mar, 17 | 74 | 94.74% | 3,508,720 | 68.85% | 29.08% | 5.54% | 50 | 108.33% | 8 | 33.33% |
| 31 Dec, 16 | 38 | 58.33% | 2,077,955 | 3.16% | 22.91% | 4.48% | 24 | 71.43% | 6 | - |
| 30 Sep, 16 | 24 | -11.11% | 2,014,374 | -7.94% | 22.60% | 3.71% | 14 | -6.67% | - | -100.00% |
| 30 Jun, 16 | 27 | -10.00% | 2,188,203 | -20.76% | 24.70% | 2.52% | 15 | - | 9 | 28.57% |
| 31 Mar, 16 | 30 | -3.23% | 2,761,451 | 2.19% | 31.29% | 3.63% | 15 | -25.00% | 7 | -12.50% |
| 31 Dec, 15 | 31 | 29.17% | 2,702,257 | 13.48% | 29.37% | 1.89% | 20 | -16.67% | 8 | - |
| 30 Sep, 15 | 24 | - | 2,381,256 | - | 39.39% | - | 24 | - | - | - |
Zynerba Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Zynerba Pharmaceuticals's stock was made by Jones Kenneth T on Oct 11 2023, selling 40,520 shares at $1.11 per share (valued at $44.81K).
Zynerba Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | 6 | 43 | 13.95% |
| Q3 2023 | 5 | 12 | 41.67% |
| Q2 2023 | 12 | 6 | 200.00% |
| Q1 2023 | 15 | 15 | 100.00% |
| Q3 2022 | 4 | 4 | 100.00% |
| Q2 2022 | 6 | 6 | 100.00% |
| Q1 2022 | 10 | - | - |
| Q3 2021 | 12 | - | - |
| Q1 2021 | 10 | - | - |
| Q2 2020 | 6 | - | - |
| Q1 2020 | 6 | - | - |
| Q4 2019 | 1 | - | - |
| Q3 2019 | 1 | - | - |
| Q2 2019 | 7 | - | - |
| Q1 2019 | 9 | - | - |
| Q4 2018 | 2 | - | - |
| Q3 2018 | 7 | - | - |
| Q2 2018 | 11 | - | - |
| Q1 2018 | 9 | - | - |
| Q4 2017 | 6 | - | - |
6 total buy trades, and 43 total sell trades (buy/sell ratio of 0.14%) were made by Zynerba Pharmaceuticals's insiders, as of Q4 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | - | - | - |
| Q3 2023 | - | 5 | - |
| Q2 2023 | - | 6 | - |
| Q1 2023 | - | 5 | - |
| Q3 2022 | - | 4 | - |
| Q2 2022 | - | 6 | - |
| Q1 2022 | - | - | - |
| Q3 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | - | - |
| Q4 2018 | - | - | - |
| Q3 2018 | 5 | - | - |
| Q2 2018 | 2 | - | - |
| Q1 2018 | 2 | - | - |
| Q4 2017 | 3 | - | - |
As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Zynerba Pharmaceuticals's stocks.
Zynerba Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| EBS | Emergent BioSolutions Inc. |
| ITCI | Intra-Cellular Therapies, Inc. |
| BFRI | Biofrontera Inc. |
| FLGC | Flora Growth Corp. |
| TKNO | Alpha Teknova, Inc. |
| ACOR | Acorda Therapeutics, Inc. |
| DRRX | DURECT Corporation |
| PAHC | Phibro Animal Health Corporation |
| SSIC | Silver Spike Investment Corp. |
| DCPH | Deciphera Pharmaceuticals, Inc. |
| HUGE | FSD Pharma Inc. |
| CLVR | Clever Leaves Holdings Inc. |
| JUPW | Safety Shot Inc |
| LSDI | Lucy Scientific Discovery Inc. |
| COLL | Collegium Pharmaceutical, Inc. |
| SXTC | China SXT Pharmaceuticals, Inc. |
| IMCC | IM Cannabis Corp. |
| EGRX | Eagle Pharmaceuticals, Inc. |
ZYNE Ownership FAQ
Who Owns Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals is owned by institutional shareholders (0.03%), insiders (6.07%), and public (93.90%). The largest institutional shareholder of Zynerba Pharmaceuticals is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is ETF Managers Trust (0.09% of total shares).
Who are the major institutional shareholders of Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals's major institutional shareholders are JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, and HARBOUR INVESTMENTS, INC.. The top five shareholders own together 0% of the company's share outstanding.
How many Zynerba Pharmaceuticals shareholders are there?
As of Mar 2024, there are 1 institutional shareholders of Zynerba Pharmaceuticals.
What percentage of Zynerba Pharmaceuticals is owned by JPMORGAN CHASE & CO?
JPMORGAN CHASE & CO owns 0 shares of Zynerba Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).
What percentage of Zynerba Pharmaceuticals is owned by BANK OF AMERICA CORP /DE/?
As of Dec 2023, BANK OF AMERICA CORP /DE/ holds 0 shares of Zynerba Pharmaceuticals (ZYNE), compromising 0% of the company, valued at $0.
What percentage of Zynerba Pharmaceuticals is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN is the third largest holder of Zynerba Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).